# Arhaus, Inc. (ARHS) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-17  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/arhs/thesis · /memo/arhs

## Financial Snapshot

---
source: coverage-next-full
ticker: ARHS
company: Arhaus, Inc.
step: 04
title: Financial Quality & Adversarial Sweep
date: 2026-06-16
---

### Step 04 — Financial Quality & Adversarial Sweep: Arhaus, Inc. (ARHS)

#### 1. Financial Statement Quality Assessment

##### Revenue Recognition
Arhaus recognizes revenue at the point of delivery to the customer, not at the point of order. This is consistent with ASC 606 (IFRS 15 equivalent) for made-to-order products with no alternative use and customer repurchase option. The policy creates the "demand comp vs. delivered comp" dynamic. [S1]

**Quality flag:** In FY2024, management disclosed a **material weakness in internal controls over financial reporting (ICFR)** related to revenue recognition controls — specifically, timing of when certain orders were deemed deliverable and revenue recognized. The material weakness was also present in the FY2023 filing. As of the FY2024 10-K, remediation was ongoing. This raises limited-but-real risk that revenue could be slightly misstated in recent quarters. The magnitude appears small (no restatement has been required), but it is an audit-quality flag for a growth company. [S1][S2]

##### Cash Flow vs. Earnings Quality

| FY | Net Income | Operating CF | FCF (OCF - CapEx) | CF Quality |
|----|-----------|-------------|-------------------|-----------|
| FY2021 | $21.1M | $97.6M | ~$54M | High (WC benefit from advance payments) |
| FY2022 | $136.6M | $77.5M | ~$23M | Low — WC reversed as backlog delivered |
| FY2023 | $125.2M | $168.7M | ~$74M | High — earnings cash-backed |
| FY2024 | $68.6M | $111.8M | ~$39M (CapEx $72M) | Moderate |
| FY2025 | $67.3M | ~$137M | ~$59M (CapEx $78M) | Moderate |

*Note: FY2022 OCF included a cash flow restatement (reclassification from $74.5M→$77.5M per Note 1 of FY2024 10-K). Not an earnings restatement — OCF was slightly restated. No impact on revenue/income. [S2]*

**Assessment:** ARHS's cash flow generally supports reported earnings quality, with the exception of FY2022 where the backlog-driven revenue surge produced abnormally high net income while OCF was suppressed by working capital build. Post-normalization, OCF tracks earnings with appropriate D&A and WC adjustments.

##### Key Accounting Policies

**Operating leases (ASC 842):** All showroom leases are on-balance-sheet as ROU assets and operating lease liabilities. The $599.7M in "total debt" on StockAnalysis is entirely operating lease liabilities — there is no financial debt. Cash interest expense is minimal (net interest income, not expense). [S1]

**Customer deposits:** Arhaus collects deposits on made-to-order furniture at time of order, which shows up as deferred revenue on the balance sheet. This is the mechanism behind the demand/delivered revenue lag. At elevated demand levels (FY2021), deposits were substantial. As the backlog normalized, this liability declined. [S1]

**Inventory:** Arhaus carries approximately $300–370M in inventory (FY2025 ~$369M per StockAnalysis), representing finished goods in its DCs awaiting delivery, as well as some raw materials for the NC upholstery facility. Inventory levels have increased with the store expansion. [S3]

##### Adjusted EBITDA Reconciliation Quality
The company's Adj. EBITDA adds back: (1) equity-based compensation, (2) other non-recurring income/expense. The adjustments are modest ($7–9M SBC) and clean. No aggressive "adjusted" items (no restructuring charges, no one-time write-offs). The Adj. EBITDA definition is straightforward and defensible. [S1]

#### 2. Statement-Quality Adjustments

| Item | Raw Reported | Adjustment | Adjusted | Rationale |
|------|-------------|-----------|---------|-----------|
| Net income (FY2025) | $67.3M | +$7.4M SBC | $74.7M | SBC is non-cash |
| EBIT (FY2025) | $88.9M | None | $88.9M | Clean |
| Gross profit (FY2025) | $536.4M | None | $536.4M | No adjustments needed |
| Debt | $0 financial debt | — | $0 | Operating leases properly classified |
| Cash (FY2025) | $253.4M | None | $253.4M | Unrestricted |

**Net cash position (FY2025):** $253.4M cash − $0 financial debt = **$253.4M net cash** (before operating leases)

#### 3. Adversarial Research Sweep

*Note: Transcript analysis not performed (coverage-next-full path). Short thesis analysis and litigation review conducted via SEC filings and web search.*

##### Short Thesis Review
**Short interest:** Low — approximately 2.81% of float (~3.97M shares). No major short campaign identified. [S4]

**Known short arguments (from analyst notes and market commentary):**
1. **Gross margin structural step-down:** Bears argue the 42.7% peak gross margin was artificially inflated by COVID-era demand surge and will not recover, settling in the 37–39% range structurally (driven by occupancy cost inflation on new showrooms).
2. **Housing market risk:** If US existing home sales remain depressed in 2025–2026 below 4.5M annualized units, ARHS comparable store sales recovery thesis fails.
3. **SG&A inflation:** Technology investment ($30M multi-year program) and legal costs (RH litigation) create SG&A headwinds that offset revenue leverage.
4. **ICFR material weakness:** Ongoing internal control weakness creates tail risk of a revenue timing restatement.
5. **Dual-class governance risk:** Friedman family controls voting; minority shareholders have limited recourse on capital allocation decisions (e.g., the $70.3M special dividend in FY2024 while earnings fell).

**Assessment of short thesis:** The short arguments are coherent but largely price-in the current multiple discount vs. peers. At 11x EV/EBITDA and ~$7.45/share vs. $12+ analyst price targets, the market is already pricing elevated risk. The dual-class risk is structural and persistent but not a near-term catalyst for decline.

##### Litigation Review

**RH Trade Secret Litigation (active as of June 2026):**
Arhaus filed suit against RH alleging misappropriation of trade secrets following the hiring of former ARHS Chief Merchandising Officer Lisa Chi by RH. The suit alleges Chi transferred proprietary design plans, vendor relationships, and product roadmap information to RH. [S5]

- **Risk to Arhaus:** Competitive intelligence loss is the primary concern; legal costs ($639K+ in FY2024 executive legal expense noted in proxy). Case likely to resolve in 1–2 years.
- **Potential upside:** If Arhaus prevails, it could receive injunctive relief limiting RH's use of proprietary information and/or damages.
- **Assessment:** Manageable legal risk; not a material financial liability for ARHS.

**Material weakness remediation risk:**
If the ICFR remediation takes longer than expected (into FY2026), it could trigger SEC inquiry or restatement risk. This remains the single most underappreciated financial risk in the ARHS story. [S1][S2]

##### Accounting Red Flags Screen
| Flag | Status | Notes |
|------|--------|-------|
| Revenue restatement | None | Cash flow reclassification only (minor) |
| Aggressive capitalization | None | CapEx is routine showroom buildout |
| Related-party transactions | Minor | Founder compensation (aircraft use ~$639K) |
| Off-balance-sheet arrangements | None (beyond standard operating leases) | Properly disclosed per ASC 842 |
| Goodwill impairment risk | N/A | No material goodwill (asset-light acquisitive model not pursued) |
| Going concern | None | Strong cash position, no financial debt |

#### 4. Balance Sheet Quality

| Item | FY2025 | FY2024 | Assessment |
|------|--------|--------|-----------|
| Cash | $253.4M | $197.5M | Strong; growing |
| Inventory | $369.5M | $297.0M | Elevated; watch for markdown risk |
| Total debt | $0 (financial) | $0 (financial) | Clean |
| Operating leases | ~$550–600M | ~$521M | Normal for retailer footprint |
| Net cash (ex-leases) | $253.4M | $197.5M | Positive |
| Current ratio | ~1.2–1.4x | ~1.2x | Adequate |

**Inventory risk flag:** Inventory increased from $297M (FY2024) to $370M (FY2025), a +24% increase on +8.5% revenue growth. This could indicate: (a) deliberate in-stock buildup for demand recovery, or (b) slower-than-expected delivery velocity requiring markdown. Warrants monitoring. [S3]

#### Source Index

| ID | Source | Detail |
|----|--------|--------|
| [S1] | SEC 10-K FY2024 | Revenue recognition, ICFR, accounting policies, Adj. EBITDA |
| [S2] | SEC 10-K FY2023 | Cash flow restatement Note 1 |
| [S3] | StockAnalysis.com | Balance sheet, inventory, quarterly data |
| [S4] | Consensus/Web search | Short interest, analyst commentary |
| [S5] | SEC filings + Web search | RH trade secret litigation, Lisa Chi |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ARHS/fundamental

## Navigation

- Overview: /stocks/arhs
- Financials (this page): /stocks/arhs/financials
- Thesis: /stocks/arhs/thesis
- Investment Memo: /memo/arhs
- Coverage universe: /stocks